Check the latest share price of Titan Biotech Ltd, along with the price target, peer comparison, quarterly results, recent news, expert analysis, shareholding pattern, and other key fundamentals to make informed investment decisions.
as on 04:01PM, 13 Jun 2025
BSE
Get live Titan Biotech Ltd share price, day's high and low, historical returns, and market stats.
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -6.56 % |
3 Month Return | -3.65 % |
1 Year Return | -18.32 % |
3 Year Return | + 90.1 % |
5 Year Return | + 513.76 % |
Market Stats | |
Previous Close | ₹430.45 |
Open | ₹429.95 |
Volume | 3,212.00 |
Upper Circuit | ₹516.50 |
Lower Circuit | ₹344.40 |
Check Titan Biotech Ltd market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
₹353.77 Cr
Return on Equity (ROE)
20.18
PE Ratio (TTM)
16.43
Return on capital employed (ROCE)
25.7
Industry PE ratio
57.39
Beta (LTM)
0.88
P/B Ratio
3.4
Dividend Yield
0.38
PEG Ratio
-4.07
Quarterly Earnings Growth YOY
-22.11
EPS (TTM)
28.64
Sector
Pharmaceuticals
Book Value
161.49
Technical Analysis
Bearish
View Technical Analysis
Investing in Titan Biotech Ltd is simple. You can open a free INDstocks investment account on the INDmoney App. Search for Titan Biotech Ltd or 524717 on the app to check live prices of the stock and click on Buy or SIP. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
For example: You can buy 10 shares of Titan Biotech Ltd or start an SIP based on the market price on each investment date.
You can easily transfer money to your stock account via the INDmoney app and start investing in stocks like Titan Biotech Ltd with just a few clicks!
Track how Titan Biotech Ltd P/E has moved over time to understand its valuation trends.
Titan Biotech Ltd in the last 5 years
Lowest (3.20x)
June 30, 2020
Today (16.43x)
June 13, 2025
Industry (57.39x)
June 13, 2025
Highest (32.11x)
October 21, 2024
Today’s Price to Earnings Ratio: 16.43x
Get the annual and quarterly financial summary of Titan Biotech Ltd, including revenue, profit, loss and more.
View detailed summary of the earnings and dividend history of Titan Biotech Ltd.
Titan Biotech Ltd’s net profit fell -19% since last year same period to ₹4.05Cr in the Q4 2024-2025. On a quarterly growth basis, Titan Biotech Ltd has generated -7.74% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Titan Biotech Ltd has declared dividend of ₹2 - translating a dividend yield of 0.89%.
Read More about DividendsView the shareholding pattern breakup of promoters, FIIs, DIIs, and retail investors in Titan Biotech Ltd.
Investors | Holdings % | Quarterly Trend | 3M change |
---|---|---|---|
Promoter Holdings | 55.88% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 44.11% | 0.00 | |
Others | 0.01% | 0.00 |
Compare market cap, revenue, PE, and other key metrics of Titan Biotech Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 353.77 | 102.75% | 0.54 | 23 | 164 | |
NA | 6.24 | 5.19% | 5.69 | NA | NA | |
NA | 81.58 | 58.65% | 0.51 | 1 | 40 | |
NA | 1,949.06 | 25.81% | 0.51 | 58 | 630 | |
NA | 69.91 | 6.88% | 0.78 | 2 | 45 |
Latest news and events in one place to help you make informed investing decisions in Titan Biotech Ltd.
Titan Biotech Reports Decline in Sales and Profit - 02 Jun, 2025
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 131.1% return, outperforming this stock by 41.0%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 55.88% of holdings in Mar 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 45.3% return, outperforming this stock by 63.6%
Price Dip
In the last 6 months, Titan Biotech stock has moved down by -44.8%
Retail Holding Down
Retail Investor have decreased holdings from 44.12% to 44.11% in Mar 2025 quarter
Profit Down
Netprofit is down for the last 3 quarters, 6.7 Cr → 4.05 Cr (in ₹), with an average decrease of 21.1% per quarter
Revenue Fall
Revenue is down for the last 4 quarters, 43.74 Cr → 36.55 Cr (in ₹), with an average decrease of 5.8% per quarter
Organisation | Titan Biotech Ltd |
Headquarters | New Delhi |
Industry | Pharmaceuticals |
CEO | Rohit Jain |
E-voting on shares | Click here to vote |
Titan Biotech Ltd share price today stands at ₹429.05, Open: ₹429.95, Previous Close: ₹430.45, High: ₹429.95, Low: ₹422, 52 Week High: ₹1017.85, 52 Week Low: ₹406.7.
Today's traded volume of Titan Biotech Ltd is 3,212.00. Which means that 3,212.00 shares of Titan Biotech Ltd were bought and sold on the stock market during today's trading session.
Today's market capitalisation of Titan Biotech Ltd is ₹353.77 Cr. Market cap or market capitalisation is the total value of a company’s outstanding shares in the stock market, calculated by multiplying the current share price by the total number of shares issued by the company.
Titan Biotech Ltd’s 52 week high is ₹1017.85 and 52 week low is ₹406.7. The current share price of Titan Biotech Ltd is ₹429.05, which is -57.85% down from its 52 week high and 5.50% up from its 52 week low.